The dual staining of alpha-smooth muscle actin (a-SMA) and CD31 showed that tumor vessels were significantly less in the Fru 2.5 group compared with the control group in the CT26 allograft tumor model (Figure 4B). The gene discussed is PECAM1; the disease is neoplasm.